# Nasal Spray Study in Sjogren's Dry Eye Disease

> **NCT05700422** · PHASE4 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 39 (actual)

## Conditions studied

- Sjogren's Syndrome
- Dry Eye

## Interventions

- **DRUG:** Varenicline Nasal Spray

## Key facts

- **NCT ID:** NCT05700422
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2024-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05700422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05700422, "Nasal Spray Study in Sjogren's Dry Eye Disease". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05700422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*